{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:01:23Z","timestamp":1790078483064,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:00:00Z","timestamp":1503446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:00:00Z","timestamp":1503446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor frequently used in combination with other antiretroviral agents for highly active antiretroviral therapy (HAART) of patients infected with the human immunodeficiency virus type 1 (HIV-1). However NVP can cause serious, life-threatening complications. Hepatotoxicity is one of the most severe adverse effects, particularly in HIV patients with chronic hepatitis C virus co-infection as these patients can develop liver toxicity after a relatively short course of treatment. However, the mechanism of NVP-associated hepatotoxicity remains unclear. This study sought to investigate the effect of NVP on protein expression in liver cells using a proteomic approach. HepG2 cells were treated or not treated with NVP and proteins were subsequently resolved by two-dimensional gel electrophoresis. A total of 33 differentially regulated proteins were identified, of which nearly 40% (13\/33) were mitochondrial proteins. While no obvious differences were observed between NVP treated and untreated cells after staining mitochondria with mitotracker, RT-PCR expression analysis of three mitochondrially encoded genes showed all were significantly up-regulated in NVP treated cells. Mitochondrial dysfunction was observed in response to treatment even with slightly sub-optimal therapeutic treatment concentrations of NVP. This study shows that NVP induces mitochondrial dysregulation in HepG2 cells.<\/jats:p>","DOI":"10.1038\/s41598-017-09321-y","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T09:48:10Z","timestamp":1502963290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Nevirapine induced mitochondrial dysfunction in HepG2 cells"],"prefix":"10.1038","volume":"7","author":[{"given":"Atchara","family":"Paemanee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wannapa","family":"Sornjai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suthathip","family":"Kittisenachai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naraporn","family":"Sirinonthanawech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3696-8390","authenticated-orcid":false,"given":"Sittiruk","family":"Roytrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6718-5041","authenticated-orcid":false,"given":"Jeerang","family":"Wongtrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6592-9852","authenticated-orcid":false,"given":"Duncan R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,23]]},"reference":[{"key":"9321_CR1","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1126\/science.1701568","volume":"250","author":"VJ Merluzzi","year":"1990","unstructured":"Merluzzi, V. J. et al. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science 250, 1411\u20131413 (1990).","journal-title":"Science"},{"key":"9321_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076587","volume":"8","author":"P Kawalec","year":"2013","unstructured":"Kawalec, P., Kryst, J., Mikrut, A. & Pilc, A. Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials. PLoS One 8, e76587 (2013).","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"9321_CR3","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/j.jinf.2014.07.018","volume":"69","author":"J Stevens","year":"2014","unstructured":"Stevens, J. & Lyall, H. Mother to child transmission of HIV: what works and how much is enough? The Journal of infection 69(Suppl 1), S56\u201362 (2014).","journal-title":"The Journal of infection"},{"key":"9321_CR4","doi-asserted-by":"publisher","first-page":"14410","DOI":"10.1073\/pnas.222366699","volume":"99","author":"J Ren","year":"2002","unstructured":"Ren, J. et al. Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc Natl Acad Sci USA 99, 14410\u201314415 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"9321_CR5","doi-asserted-by":"crossref","unstructured":"Hu, W. S. & Hughes, S. H. HIV-1 reverse transcription. Cold Spring Harb Perspect Med 2 (2012).","DOI":"10.1101\/cshperspect.a006882"},{"key":"9321_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nsmb.2223","volume":"19","author":"K Das","year":"2012","unstructured":"Das, K., Martinez, S. E., Bauman, J. D. & Arnold, E. HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism. Nat Struct Mol Biol 19, 253\u2013259 (2012).","journal-title":"Nat Struct Mol Biol"},{"key":"9321_CR7","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.2217\/fmb.15.106","volume":"10","author":"N Sluis-Cremer","year":"2015","unstructured":"Sluis-Cremer, N., Wainberg, M. A. & Schinazi, R. F. Resistance to reverse transcriptase inhibitors used in the treatment and prevention of HIV-1 infection. Future Microbiol 10, 1773\u20131782 (2015).","journal-title":"Future Microbiol"},{"key":"9321_CR8","volume":"12","author":"L Mbuagbaw","year":"2016","unstructured":"Mbuagbaw, L. et al. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naive individuals. Cochrane Database Syst Rev 12, CD004246 (2016).","journal-title":"Cochrane Database Syst Rev"},{"key":"9321_CR9","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0149-2918(98)80105-7","volume":"20","author":"RB Pollard","year":"1998","unstructured":"Pollard, R. B., Robinson, P. & Dransfield, K. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Clin Ther 20, 1071\u20131092 (1998).","journal-title":"Clin Ther"},{"key":"9321_CR10","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1097\/QAD.0b013e32835f1db0","volume":"27","author":"Z Shubber","year":"2013","unstructured":"Shubber, Z. et al. Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis. Aids 27, 1403\u20131412 (2013).","journal-title":"Aids"},{"key":"9321_CR11","doi-asserted-by":"crossref","unstructured":"Milpied-Homsi, B., Moran, E. M. & Phillips, E. J. Antiviral drug allergy. Immunol Allergy Clin North Am 34, 645-662, ix (2014).","DOI":"10.1016\/j.iac.2014.04.011"},{"key":"9321_CR12","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1021\/tx800177k","volume":"21","author":"J Chen","year":"2008","unstructured":"Chen, J., Mannargudi, B. M., Xu, L. & Uetrecht, J. Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash. Chem Res Toxicol 21, 1862\u20131870 (2008).","journal-title":"Chem Res Toxicol"},{"key":"9321_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.apjtm.2016.04.015","volume":"9","author":"J Wongtrakul","year":"2016","unstructured":"Wongtrakul, J. et al. Nevirapine induces apoptosis in liver (HepG2) cells. Asian Pacific journal of tropical medicine 9, 547\u2013553 (2016).","journal-title":"Asian Pacific journal of tropical medicine"},{"key":"9321_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","volume":"28","author":"HH Gerets","year":"2012","unstructured":"Gerets, H. H. et al. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell biology and toxicology 28, 69\u201387 (2012).","journal-title":"Cell biology and toxicology"},{"key":"9321_CR15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1124\/dmd.110.035873","volume":"39","author":"L Guo","year":"2011","unstructured":"Guo, L. et al. Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metab Dispos 39, 528\u2013538 (2011).","journal-title":"Drug Metab Dispos"},{"key":"9321_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2131\/jts.38.741","volume":"38","author":"JL Fang","year":"2013","unstructured":"Fang, J. L. & Beland, F. A. Differential responses of human hepatocytes to the non-nucleoside HIV-1 reverse transcriptase inhibitor nevirapine. The Journal of toxicological sciences 38, 741\u2013752 (2013).","journal-title":"The Journal of toxicological sciences"},{"key":"9321_CR17","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","volume":"20","author":"DN Perkins","year":"1999","unstructured":"Perkins, D. N., Pappin, D. J., Creasy, D. M. & Cottrell, J. S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551\u20133567 (1999).","journal-title":"Electrophoresis"},{"key":"9321_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44\u201357 (2009).","journal-title":"Nat Protoc"},{"key":"9321_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research 37, 1\u201313 (2009).","journal-title":"Nucleic acids research"},{"key":"9321_CR20","doi-asserted-by":"publisher","first-page":"D284","DOI":"10.1093\/nar\/gki078","volume":"33","author":"H Mi","year":"2005","unstructured":"Mi, H. et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic acids research 33, D284\u2013288 (2005).","journal-title":"Nucleic acids research"},{"key":"9321_CR21","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1101\/gr.772403","volume":"13","author":"PD Thomas","year":"2003","unstructured":"Thomas, P. D. et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome research 13, 2129\u20132141 (2003).","journal-title":"Genome research"},{"key":"9321_CR22","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk, D. et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic acids research 43, D447\u2013452 (2015).","journal-title":"Nucleic acids research"},{"key":"9321_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1310\/NXJU-9ERQ-ADWW-UC5X","volume":"5","author":"M Duong","year":"2004","unstructured":"Duong, M. et al. Usefulness of therapeutic drug monitoring of antiretrovirals in routine clinical practice. HIV Clin Trials 5, 216\u2013223 (2004).","journal-title":"HIV Clin Trials"},{"key":"9321_CR24","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1021\/acs.chemrestox.6b00250","volume":"29","author":"SJ Dekker","year":"2016","unstructured":"Dekker, S. J., Zhang, Y., Vos, J. C., Vermeulen, N. P. & Commandeur, J. N. Different Reactive Metabolites of Nevirapine Require Distinct Glutathione S-Transferase Isoforms for Bioinactivation. Chem Res Toxicol 29, 2136\u20132144 (2016).","journal-title":"Chem Res Toxicol"},{"key":"9321_CR25","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0090-9556(24)14960-4","volume":"27","author":"DA Erickson","year":"1999","unstructured":"Erickson, D. A., Mather, G., Trager, W. F., Levy, R. H. & Keirns, J. J. Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450. Drug Metab Dispos 27, 1488\u20131495 (1999).","journal-title":"Drug Metab Dispos"},{"key":"9321_CR26","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1021\/tx300172s","volume":"25","author":"AM Sharma","year":"2012","unstructured":"Sharma, A. M., Li, Y., Novalen, M., Hayes, M. A. & Uetrecht, J. Bioactivation of nevirapine to a reactive quinone methide: implications for liver injury. Chem Res Toxicol 25, 1708\u20131719 (2012).","journal-title":"Chem Res Toxicol"},{"key":"9321_CR27","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1124\/dmd.108.024851","volume":"37","author":"B Wen","year":"2009","unstructured":"Wen, B., Chen, Y. & Fitch, W. L. Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4. Drug Metab Dispos 37, 1557\u20131562 (2009).","journal-title":"Drug Metab Dispos"},{"key":"9321_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2008.06.043","volume":"134","author":"C Meisinger","year":"2008","unstructured":"Meisinger, C., Sickmann, A. & Pfanner, N. The mitochondrial proteome: from inventory to function. Cell 134, 22\u201324 (2008).","journal-title":"Cell"},{"key":"9321_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature12985","volume":"505","author":"JR Friedman","year":"2014","unstructured":"Friedman, J. R. & Nunnari, J. Mitochondrial form and function. Nature 505, 335\u2013343 (2014).","journal-title":"Nature"},{"key":"9321_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.mam.2010.03.002","volume":"31","author":"V Shoshan-Barmatz","year":"2010","unstructured":"Shoshan-Barmatz, V. et al. VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol Aspects Med 31, 227\u2013285 (2010).","journal-title":"Mol Aspects Med"},{"key":"9321_CR31","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.bbabio.2010.01.031","volume":"1797","author":"V De Pinto","year":"2010","unstructured":"De Pinto, V. et al. Characterization of human VDAC isoforms: a peculiar function for VDAC3? Biochim Biophys Acta 1797, 1268\u20131275 (2010).","journal-title":"Biochim Biophys Acta"},{"key":"9321_CR32","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.febslet.2010.02.049","volume":"584","author":"V De Pinto","year":"2010","unstructured":"De Pinto, V., Messina, A., Lane, D. J. & Lawen, A. Voltage-dependent anion-selective channel (VDAC) in the plasma membrane. FEBS Lett 584, 1793\u20131799 (2010).","journal-title":"FEBS Lett"},{"key":"9321_CR33","doi-asserted-by":"publisher","first-page":"28006","DOI":"10.1074\/jbc.271.45.28006","volume":"271","author":"T Rostovtseva","year":"1996","unstructured":"Rostovtseva, T. & Colombini, M. ATP Flux Is Controlled by a Voltage-gated Channel from the Mitochondrial Outer Membrane. J. Biol. Chem. 271, 28006\u201328008 (1996).","journal-title":"J. Biol. Chem."},{"key":"9321_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1042\/bj3580147","volume":"358","author":"D Gincel","year":"2001","unstructured":"Gincel, D., Zaid, H. & Shoshan-Barmatz, V. Calcium binding and translocation by the voltage-dependent anion channel: a possible regulatory mechanism in mitochondrial function. Biochem. J. 358, 147\u2013155 (2001).","journal-title":"Biochem. J."},{"key":"9321_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/15216540152845902","volume":"52","author":"E Blachly-Dyson","year":"2001","unstructured":"Blachly-Dyson, E. & Forte, M. VDAC Channels. IUBMB Life 52, 113\u2013118 (2001).","journal-title":"IUBMB Life"},{"key":"9321_CR36","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1177\/0192623313503519","volume":"42","author":"K Gardner","year":"2014","unstructured":"Gardner, K., Hall, P. A., Chinnery, P. F. & Payne, B. A. HIV treatment and associated mitochondrial pathology: review of 25 years of in vitro, animal, and human studies. Toxicol Pathol 42, 811\u2013822 (2014).","journal-title":"Toxicol Pathol"},{"key":"9321_CR37","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1128\/AAC.38.12.2743","volume":"38","author":"JL Martin","year":"1994","unstructured":"Martin, J. L., Brown, C. E., Matthews-Davis, N. & Reardon, J. E. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrobial agents and chemotherapy 38, 2743\u20132749 (1994).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"9321_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0006-291X(89)92611-9","volume":"161","author":"EL White","year":"1989","unstructured":"White, E. L. et al. Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerases. Biochem Biophys Res Commun 161, 393\u2013398 (1989).","journal-title":"Biochem Biophys Res Commun"},{"key":"9321_CR39","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1016\/S0021-9258(17)40396-6","volume":"252","author":"A Bolden","year":"1977","unstructured":"Bolden, A., Noy, G. P. & Weissbach, A. DNA polymerase of mitochondria is a gamma-polymerase. J Biol Chem 252, 3351\u20133356 (1977).","journal-title":"J Biol Chem"},{"key":"9321_CR40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/135965350300800410","volume":"8","author":"O Miro","year":"2003","unstructured":"Miro, O. et al. Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy. Antivir Ther 8, 333\u2013338 (2003).","journal-title":"Antivir Ther"},{"key":"9321_CR41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/135965350501000216","volume":"10","author":"B Setzer","year":"2005","unstructured":"Setzer, B., Schlesier, M., Thomas, A. K. & Walker, U. A. Mitochondrial toxicity of nucleoside analogues in primary human lymphocytes. Antivir Ther 10, 327\u2013334 (2005).","journal-title":"Antivir Ther"},{"key":"9321_CR42","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1128\/AAC.46.8.2687-2691.2002","volume":"46","author":"AA Pilon","year":"2002","unstructured":"Pilon, A. A. et al. Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor. Antimicrobial agents and chemotherapy 46, 2687\u20132691 (2002).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"9321_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/QAI.0b013e3181799662","volume":"48","author":"L Karamchand","year":"2008","unstructured":"Karamchand, L., Dawood, H. & Chuturgoon, A. A. Lymphocyte mitochondrial depolarization and apoptosis in HIV-1-infected HAART patients. J Acquir Immune Defic Syndr 48, 381\u2013388 (2008).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9321_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/hep.23647","volume":"52","author":"A Blas-Garcia","year":"2010","unstructured":"Blas-Garcia, A. et al. Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells. Hepatology 52, 115\u2013125 (2010).","journal-title":"Hepatology"},{"key":"9321_CR45","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bcmd.2011.06.005","volume":"47","author":"A Leecharoenkiat","year":"2011","unstructured":"Leecharoenkiat, A. et al. Increased oxidative metabolism is associated with erythroid precursor expansion in beta0-thalassaemia\/Hb E disease. Blood cells, molecules & diseases 47, 143\u2013157 (2011).","journal-title":"Blood cells, molecules & diseases"},{"key":"9321_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bcmd.2011.11.004","volume":"48","author":"S Sriiam","year":"2012","unstructured":"Sriiam, S. et al. Proteomic analysis of hemoglobin H-constant spring (Hb H-CS) erythroblasts. Blood cells, molecules & diseases 48, 77\u201385 (2012).","journal-title":"Blood cells, molecules & diseases"},{"key":"9321_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153831","volume":"11","author":"K Khungwanmaythawee","year":"2016","unstructured":"Khungwanmaythawee, K. et al. Mitochondrial Changes in beta0-Thalassemia\/Hb E Disease. PLoS One 11, e0153831 (2016).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09321-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:13:33Z","timestamp":1750806813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09321-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,23]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["9321"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-09321-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,23]]},"assertion":[{"value":"3 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9194"}}